Insights from
UBC's Expert Voices

Women's depression is often framed as a hormonal imbalance of the body. Men's? A failure of will. These aren't just outdated ideas — they're active barriers to diagnosis, treatment, and survival. As treatment-resistant depression challenges conventional medicine, psychedelic-assisted therapy is emerging not only as a clinical option, but as a way to dismantle the very stigmas that keep people from seeking help in the first place.

As psychedelics move toward potential FDA approval, Oregon’s psilocybin service centers offer early lessons in patient-centered care. This article examines real-world practices in preparation, dosing, facilitation, and integration—and what they may reveal about future clinical use.